DLD Asset Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q2
Sell
-100,000
Closed -$1.9M 129
2019
Q1
$1.9M Buy
+100,000
New +$1.62M 0.07% 74

Other funds holding OSIR

DLD Asset Management's OSIR Position: Q2 2019 in Review

DLD Asset Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q2 2019, closing a stake of 100,000 shares — an estimated $1.9M sold.

DLD Asset Management first reported a position in OSIR in Q1 2019 and held it in 1 quarter. The position peaked at $1.9M in Q1 2019. 1 fund tracked by Wall St. Rank holds OSIR as of Q2 2019.

  • DLD Asset Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
  • DLD Asset Management sold 100,000 Osiris Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $1.9M.
  • DLD Asset Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q1 2019 and held it in 1 quarter.
  • DLD Asset Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.9M in Q1 2019.
  • 1 fund tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q2 2019.

Based on DLD Asset Management's 13F filing for Q2 2019, filed 14 Aug 2019.